Skip to main content

Table 2 GVHD incidences in allogeneic HSCT recipients

From: Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia

Parameters

N = 24, (%)

Acute GVHD

 I

4 (16.7%)

 II

2 (8.35%)

 III

4 (16.7%)

 IV

2 (8.35%)

Chronic GVHD

 Lim

3 (12.5%)

 Ext

3 (12.5%)

  1. HSCT hematopoietic stem cell transplantation, aGVHD acute graft-versus-host disease, cGVHD chronic graft-versus-host disease, Ext extensive, Lim limited
Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us